AKT3 Mutation in Melanoma
Author Information
Author(s): Davies M A, Stemke-Hale K, Tellez C, Calderone T L, Deng W, Prieto V G, Lazar A J F, Gershenwald J E, Mills G B
Primary Institution: The University of Texas MD Anderson Cancer Center
Hypothesis
To determine the prevalence of AKT E17K mutations in melanoma.
Conclusion
The study identified a novel AKT3 E17K mutation in melanoma, marking the first report of AKT mutations in this cancer type.
Supporting Evidence
- Two lymph node metastases from one patient had the AKT3 E17K mutation.
- Two melanoma cell lines were identified with AKT3 E17K mutations.
- AKT3 E17K mutation results in activation of AKT in melanoma cells.
Takeaway
Researchers found a new mutation in a gene called AKT3 in some melanoma tumors, which could help us understand this aggressive skin cancer better.
Methodology
The study analyzed 137 melanoma specimens and 65 melanoma cell lines for AKT mutations using mass spectroscopy-based detection.
Limitations
DNA from the primary tumor of the patient with the AKT3 mutation was not available for analysis.
Participant Demographics
The specimens were primarily from metastatic lesions, including lymph nodes and soft tissue.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website